WO1993025897A1 - Diagnostic method for detection of active atherogenesis - Google Patents
Diagnostic method for detection of active atherogenesis Download PDFInfo
- Publication number
- WO1993025897A1 WO1993025897A1 PCT/US1993/005520 US9305520W WO9325897A1 WO 1993025897 A1 WO1993025897 A1 WO 1993025897A1 US 9305520 W US9305520 W US 9305520W WO 9325897 A1 WO9325897 A1 WO 9325897A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- subclasses
- gelatinous
- layers
- discrete
- separating
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
Definitions
- This invention relates generally to a method of detecting active atherogenesis. More particularly, this invention relates to a diagnostic method for the reliable detection of active atherogenesis involving the separation and quantification of atherogenic and other lipoproteins.
- Atherosclerosis is a degenerative disease of the arteries characterized by thickening and hardening of their walls. Since atherosclerosis occurs in virtually epidemic proportions, the need for a diagnostically accurate screening method cannot be overstated.
- the ⁇ 2 -fraction is formed under pathological conditions by chylomicrons of liver origin and their remnants, or NNLDL (very very low density lipoproteins), the pre-/3 2 fraction by VLDL (very low density lipoproteins) and the p- ⁇ _ fraction by IDL (intermediate low density lipoproteins, DDL, and Lp(a). (Table I, pattern 4 and Table II, pattern 6).
- the ⁇ , -electrophoretic fraction revealed mostly ⁇ 1Y -subfraction composed from VVHDL (very very high density lipoproteins) and an albumin-FFA-complex, as well as of ⁇ lx -subfraction (main mass of HDL,), and ⁇ ix- TRA i L containing HDL, (high density lipoproteins) and associated lipoproteins (Table I, pattern 5).
- Serum cholesterol levels are insignificantly different or similar in groups of patients with proven coronary heart disease, when compared to groups of clinically healthy people, or to groups of individuals with proven (angiographically) absence of coronary heart disease.
- the easiest explanation my be visible in pure analytical mathematics: both classes of serum lipoproteins, LDL and HDL, extremely rich on cholesterol, are behaving in cases with CAD (coronary artery disease) in adverse, opposite directions, so that an analytical gain in LDL-cholesterol concentrations may be almost, or completely scored out by an analytical loss of HDL-cholesterol concentrations.
- CAD coronary artery disease
- Figure 3 is a schematic representation of molecular electrophoresis based on use of novel systems of discrete nonsequential multitudinous gelous molecular sieves with specific separation coefficients;
- Figure 4 illustrate the ability of molecular electrophoresis to accurately reflect changes in the quantities of all lipoprotein classes and subclasses
- FIG. 5 illustrates different pathologic values in different lipoprotein classes
- Figure 6 is a spectrophotometric pattern from a known healthy human being
- Figure 7 is a spectrophotometric pattern from a human being with mildly active atherogenesis
- Figure 8 is a spectrophotometric pattern from a human being with severe active atherogenesis.
- K D and K R for each discrete separating gelatinous layer differs from an adjacent layer by a significant discontinuous and nonsequential value
- the thalnt invention further relates to a method of detecting active atherogenesis from a human sample comprising the steps of:
- Atherosclerosis is a degenerative disease of the arteries characterized by thickening and hardening of the artery walls.
- An atherogenic lipoprotein is a lipoprotein which, if not present in a human sample at a mean value, may lead to atherosclerosis.
- a mean value may be a normal value.
- Active atherogenesis is a process characterized by abnormal values of atherogenic lipoproteins. Thus, it is of critical importance to identify and quantify atherogenic lipoproteins in order to detect active atherogenesis, thereby enabling one to prevent atherosclerosis.
- the present invention relates to a method of determining mean values of lipoprotein classes and subclasses comprising the steps of:
- molecular electrophoresis shall mean a process of separating particles and macromolecules by transporting said particles and macromolecules in a homogeneous electric field through a system of molecular filters of increasing density, wherein the specific K D and/or K R directs the particle size of retained particles.
- K D and/or K R directs the particle size of retained particles.
- the present invention further relates to methods of detecting active atherogenesis from a human sample comprising the steps of: (a) providing a system of multilayered, discrete, discontinuous, nonsequential gels for molecular electrophoresis of biological particles and macro ⁇ molecules, comprising at least about five discrete separating gelatinous layers, wherein each gelatinous layer is defined by specific separation coefficients represented by K ⁇ and K R for the analyzed group of molecules which direct the concentration of the medium and density of netting of each gelatinous layer, and wherein the value of
- K ⁇ and K R for each discrete separating gelatinous layer differs from an adjacent layer by a significant discontinuous and nonsequential value
- the samples of biological particles and macromolecules from human beings to be added to the system for molecular electrophoresis may be collected in any manner.
- the samples may be obtained from blood.
- the blood may be pretreated, using ultracentrification methods such as centrification, and the like.
- molecular electrophoresis is used because of its superior ability to separate and quantify. Generally, a statistically valid number of samples is used to determine mean values.
- the statistically valid number of samples is collected from human beings of a given geographical area.
- molecular electrophoresis is used an effective number of times with samples from different known healthy human beings.
- a known healthy human being is a person with a proven absence of artery diseases, as indicated by conventional testing methodology.
- An effective number of times should be construed to mean at least about 25 times, more preferably at least about 35 times.
- the resulting quantities of separated lipoprotein classes and subclasses amy be averaged to give mean values.
- the mean values may also be referred to as predetermined mean values.
- mean values of lipoprotein classes and subclasses may vary, depending upon the given geographical area of the human beings who provide the biological samples. Furthermore, the mean values may vary depending upon the race, culture or ethnicity of the human beings who provide biological samples. For purposes of this invention, the term "given geographical area" is intended to include groups of human beings classified by common culture, race or ethnicity. For instance, the mean values determined from human beings in Japan may differ from those of Scandinavia. Pre- drably, the values obtained from a sample are compared to mean values obtained from samples p: vided by human beings of the same given geographical area.
- lipoprotein classes and their subclasses are presented for proper understanding of th.. significance of the present invention. There is a certain, although not yet fully established, difference between a subclass and a remnant. Subclasses are regularly appearing (e.g. under normal almost constant and well reproducible flotation rates). Remnants are physically and/or physico-chemically not well-defined mixtures of metabolites, originated at specific metabolic steps (e.g. chylomicrons, very low density lipoproteins, etc.). Chylomicrons (CHY) have mean concentrations up to 50 mg% in the serum of a fasting, healthy person. Postprandially, CHY may increase up to 500%, from
- pathologic hyper-chylomicronemia may be characterized by an increase of 500 to 1000%, or even higher concentrations of these metabolites in the patient's circulation. Isolated hyper-chylomicronemia depicts the postprandial stage.
- chylomicrons remnants (CHY-R) were largely unknown and/or ignored. Since there particles lack significant amounts of cholesterol and their arterial permeability is very low, the few individuals with a deficiency of lipoprotein lipase, or apoprotein C-II, did not suffer from premature atherosclerosis, although they have enormous amounts of these particles in the circulation.
- the above- described large lipoprotein particles are also know as very very low density lipoproteins (VVLDL).
- VVLDL very very low density lipoproteins
- Inherited enzyme defects such as chylomicronemia syndrome, or Apo-C-II-Deficiency, are examples of the above-described conditions. These remnants are not atherogenic.
- VLDL Very low density lipoproteins
- the highest levels of VLDL are observed as active atherosclerosis in severe cases of familial hypertriglyceridemias.
- the NLDL subclasses as probably all other subclasses and/or remnants, represent a scale of similar metabolic products of which each subclass is analytically distinguishable and has reproducible characteristics. While the chemico-physical composition of these metabolic by-products may be qualitatively, but not quantitatively similar, their patho-physiological features may be quite different.
- the first group of remnants of VLDL is characterized by "larger" molecules, as compared to the second group that are still very heterogeneous, characterized by a density of less than about 1.006 g/ml and particle size equal or greater than about
- the second subpopulation of the VLDL remnants with a particle size of approximately 350-320 A, and hydrated densities of about 1.010 g/ml is richer on apolipoprotein B and on cholesterol (approximately 30%), but, in contrast to the first group depleted in triglycerides (approximately 31 %) and the apolipoprotein E and C concentrations when related to that of apo B.
- the differences in apo E content are known to influence the metabolic fate of these remnants.
- the hydrated densities of small VLDL are about 1.010 g/ml.
- Metabolism of triglyceride-rich lipoproteins largely determines the high density lipoprotein (HDL) cholesterol levels.
- the delayed clearance of dietary fat that is, an extended postprandial lipemia, may induce the uptake of triglyceride-rich remnants by arterial cells, resulting in an intracellular accumulation of cholesterol esters and in the subsequent development of atherogenic foam cells.
- Subjects with low levels of subclass HDL_. are more prone to CAD because of their delayed clearance of triglyceride-rich chylomicrons.
- IDL intermediate density lipoproteins
- the IDL class of serum lipoproteins is a heterogenous fraction containing VLDL remnants and a S f of less than about 20 LDL. It has been considered as a metabolic intermediate positioned between VLDL and LDL and as the end product of the action of the plasma-lipolysis. In hypertriglyceridemic subjects, apolipoprotein-
- IDL B enters directly into IDL and that about 1/4 to 1/3 of newly synthesized apo-B enters plasma by this route. Separating the IDL by the ultracentrifuge at a density less than about 1.019 g/ml, determined S f * of about 12-20 * .
- IDL mass and IDL cholesterol are related to an increased risk of coronary artery disease in humans. Additionally, in patients with peripheral vascular, disease, the sum of IDL molecules had an average molecular weight of about 4.50 ⁇ 0.22 x 10 6 daltons, which was not significantly different from about 4.59 ⁇ 0.21 10 6 daltons found in a control group.
- LDL and IDL indicate that an IDL compartment consisted of two closely connected subcompartments, one of which was outside the immediate circulation. Furthermore, part of IDL is accepted directly by peripheral cells. Concentrations higher than about 35 mg% of IDL class of lipoproteins in human serum are pathologic. Analytically determined concentrations of IDL in the human circulation express only part (e.g. the intravascular portion) of the level of this lipoprotein. Nevertheless, it is presently the most valuable metabolic sign of the atherogenic conditions which may be characterized by relatively low serum concentrations of total cholesterol and total triglycerides as well.
- LDL low density lipoprotein
- a fractionation and ultracentrifugation of the 1.006 g/ml to 1.09 g/ml density range yielded two subspecies of lipoprotein are present in the 1.006 to 1.019 g/ml density range and three subspecies in the 1.019 to 1.063 g/ml density range.
- the concentrations of low density lipoproteins (LDL) are primary and equally critical markers as the IDL of active atherogenesis. The LDL concentrations are dependent upon movements of their LDL 3 subclass. A 50% increase in LDL concentration, or in concentration of its LDL 3 subclass, is pathognomonic.
- the LDL subclasses may also possess different physico-chemical properties (e.g. chemical composition, particle size, molecular weight and conformation) under different pathological conditions. Heterogeneity exists in human LDL group of subspecies.
- the kinetics of the subclasses depend, very importantly, on the content of apolipoprotein-B which is known to have slower kinetic than those of the other apolipoproteins (e.g. apolipoprotein E and C). Therefore, subclasses with higher level of apo B (e.g. in molecularly smaller LDL 3 subclass) are characterized by slower metabolic kinetic rate than those with lower levels of apo B, mixed even with apo E and apo C (e.g. in molecularly larger LDLj subclass). These kinetic conditions, however, do not fully explain why the LDLj subclass is, under normal conditions, quantitatively the most concentrated of the LDL subclasses, as it would provide some kind of LDL pool.
- LDL 3 subclass particles Particles of LDL 3 subclass are distributed into two compartments : about 40% into the circulation and the rest into the intercellular space of the human body.
- An obstruction to this natural metabolic trend results in the accumulation of the relatively molecularly small and dense LDL 3 subclass particles in circulation (mean molecular weight about 1,500,000 to about 2,400,000 daltons).
- the buoyant lipoprotein particles, which belong to the LDL class are in fact the LDL, subclass of mean molecular weight of about 3,000,000 to about 3,500,000 daltons, having on the surface of its molecules not only apolipoprotein B 100 , but also some apo E and apo
- LDL in humans is largely resistant to dietary changes. Even an addition of large quantities of cholesterol to the diet does not change the composition, nor particle size of LDL. Nevertheless, as patients with hyper-apo-B lipoproteinemia undergo weight reduction, the composition of LDL particles commonly changes.
- MDL medium density lipoprotein
- HDL high density lipoproteins
- the HDL class having a density of about 1.063 to 1.21 g/ml, may be separated into the HDL, subclass, defined by a density of about 1.09 g/ml, as well as with F 1-2 , less than about 9 and further into the HDL 2 subclass, characterized by a density of about 1.15 g/ml and F 1 2 , of about 9-3.5.
- the major HDL 3 subclass has a density of about 1.125 to 1.210 g/ml with the mean density of about 1.18 g/ml and F ⁇ . 2 . of about 3.15 - 0.0.
- the lipoprotein class HDL has a simple relationship to atherogenesis.
- the multilayered molecular filtration systems in accordance with the invention comprise a series of at least about 5 discontinuous molecular sieves which are effective to separate particles according to a broad range of molecular weights when arranged in a regular or irregular, i.e., sequential or nonsequential, successions manner such that selected molecules or molecular groups are retained by the specific "binding" or sieving layers of the filtration system. The largest molecules are engaged by the first sieving layer, while all other molecules of less size pass into the next layer.
- next sieve selectively keeps groups of the next large molecules, but releases the rest of the molecules of lesser size until separation of the molecular groups is completed.
- the filtration system may contain a number of non- sieving or "nonbinding" layers which function to increase the resolution of the separation in certain cases.
- the multilayered molecular filtration systems comprise a series of at least about 5 discontinuous molecular sieves.
- the multilayer molecular filtration systems comprise a series of at least about 8 discontinuous molecular sieves.
- the multilayer molecular filtration systems comprise a series of at least about 12 discontinuous molecular sieves.
- the precise number of molecular sieves, or layers, to be used may depend upon the identity of a specific lipoprotein class or subclass to be separated and quantified.
- the separating gelatinous layers may be prepared from all known media including, but not limited to, cellulose acetate, starch gels, agar-gels, agarose-gels, gels of agarose derivatives, polyacrylamide gels, gradient polyacrylamide gels of different gradient (e.g., 2% to 27% of PAA and 4% to 30% of PAA), pore gradient polyacrylamide gels, mixtures of, or combinations of polyacrylamide gels and different derivatives of agarose or other polysaccharides, immunofixative or biospecific sorbants, as well as any of the above gels with addition of protein- complexes-forming variants (SDS), urea, or emulators (TRITONS), or glass adhesives, etc.
- the gels may be solid, semifluid or fluid.
- the system is most advantageous in separations and/or determinations of molecular weights of unknown particles, or those mixtures of particles with very broad molecular sizes and weights or mixtures of very small as well as very large particles.
- the discrete system of layers filters-up, or otherwise separates macromolecular mixtures according to their molecular sizes in such a manner that each of the layers excluded (or retains, or delays) groups of molecules of higher order and releases all other molecules of lower order, e.g., of smaller molecular sizes, until the groups of the smallest molecular size are retained at the end of the mediae while none of the molecules are lost.
- An optimal composition of discrete layers may be selected or developed using adequate molecular standards and/or molecular markers covering the entire molecular
- Figure 3
- SUBSTITUTE SHEET The procedure for making a discrete system of specific molecular sieves or filters includes: empiric or experimental selection between sieves and specific binders
- the discrete layers of the gelatinous polymers are obtained by polymerization (at elected various degrees) of recrystallized N-methylol-acrylamide with a bifunctional acrylic or allylic compound (e.g., BIS or DATD) forming a three- dimensional, cross-linked sieve of the resulting polymer having different acrylamide monomer concentrations, e.g., up to 36% of the acryl monomer.
- a free-radical catalyst e.g., potassium persulfate, riboflavin or TEMED, was added, as well as a sodium chloride and/or TRIS, or barbital, or similar buffer solution to provide the intended concentration of acrylamide monomer
- each layer is prepared individually and casted (layered) into pre- prepared glass column, capillaries, circular dishes, or pre-assembled macro- or micro- plates in the molds.
- layers containing gradients are prepared using conventional linear or exponential gradient makers (e.g., LKB-217-MULTIPHOR II, or others).
- Repel Silane and/or Bind Silane (LKB) may be applied, if the gels are to be bound or repelled off the glass plate.
- the above-described PAA gels may be modified and/or filled with agarose, sepharose, agarose derivatives, etc.
- PAAG polyacrylamide gel(s) PAAG polyacrylamide gel(s)
- the layers are filled starting from the bottom of the molds.
- the "stacking gels" are layered as the last layer.
- any known techniques can be employed for the construction of the applicator gels with precast sample wells (capable of absorbing from about 5 ⁇ l to about 80 ⁇ l sample volumes).
- Construction of the final system of specific layers is prepared in any quantity, quality, physical form, composition and sequence.
- the borderlines of the layers may be constructed with sharp, visible edges (for example if the previous layer is fully gelatinized, when the following one is being overlaid) or in unbroken confluent fashion.
- Semiliquid or liquid gelatinous forms which do not change their physical status in time, although fully polymerized, have to be fitted into their containers (of any shape) in order to t vent a mixing of materials.
- the discrete layers may be particularly efficient as system of almost identical or widely varying layers, because of their optimal composition, structure or length or shape or gradation of changes in their quality or composition.
- the final shape of these discrete systems of molecular sieves may be manufactured in any thickness and usable forms in large or small (e.g. microplates) plates with glasseous or plastic supports, columns in glass tubes, or in capillaries, chromatographic columns, etc.
- gel-plates of various sizes from 125 x 250 mm, allowing the simultaneous separation of up to 96 biological samples - down to 50 x 50 mm, allowing the simultaneous separation of 9 samples and only one standard
- the preservation of gels in glass plates, containing analytical systems of discrete and/or discontinuous gelatinous layers may be preserved by immersion into a buffer solution as well as by packing them in storage bags. In such manner, it will be possible to handle their shipment and other usual commercial handling.
- the above-described gel-casting forms e.g. plates, tubes, capillaries, etc. should be useful with any known electrophoretic procedure.
- the optimal composition of the multitudinous, discrete, nonsequential gelatinous layers may be prepared or developed by determination of partition (K D ) and/or retardation (K R ) coefficients, calculated for the selected molecular groups of the analyzed mixture.
- All known forms of low or high voltage (vertical, horizontal, radial, capillary, etc.) electrophoresis, electrofocussing, chromatography, etc. may be utilized for separation of macromolecules.
- the mode of distribution of mixed macromolecules throughout the mediae may also be strongly dependable on the available instrumenta ⁇ tion. However, once the best fitting instrumentation is established, it may be easily standardized. Specific electrophoretic mA, V, V-hrs. (buffer strength, pH continuity, discontinuity, etc.) have to be established.
- a Pulse Field Electrophoresis may also be employed.
- the filtration system may contain a number of nonsieving or "nonbinding" layers which function to increase the resolution of the separation in certain cases.
- noncontinuous pore size gradients created by variations in acrylamide concentrations are most critical factors in function of the discontinuous, nonsequential molecular filters, because they represent a sieving barrier for movement of entire classes of lipoproteins, characterized by certain molecular sizes. Therefore, only molecules of certain critical hydrated density and/or molecular size are selectively retained and retarded by a unique layer, thus all others are passed through the next unique, equilibrial layer for further separation.
- Very sharp zones of single or individual lipoprotein subunits are first predetermined by discrete gradients, which limit their migration throughout gradients with continuously increasing polyacrylamide concentrations, characterized by fradually reducing pore size and increasing viscosity, caused the front of the molecular group to move more slowly than the rear of the group (trapped in the net of this kind of gel) counteract the diffusion and compresses the molecular sorority into tight zone again.
- Coronary heart or artery disease in North America is further characterized by insignificant differences in total lipoprotein concentrations and, what is even more peculiar, by equally insignificant differences in total cholesterol concentrations.
- LDL which has been known for a long time, to transfer from plasma into the arterial wall in vivo.
- the complete spectra of serum lipoproteins includes four main classes and as many as eight subclasses.
- Serum cholesterol concentrations analyze only one case, while serum lipid levels consider three classes. Additionally, calculated values may be avoided, for example of " ⁇ - cholesterol", or so called “LDL-cholesterol", handicapped by unacceptable analytical errors (up to ⁇ 30%) and, in addition, to extreme sensitivity (e.g. triglyceride determinations) to strict 12-14 hours fasting specimens.
- ⁇ - cholesterol or so called “LDL-cholesterol”
- LDL-cholesterol Low-cholesterol
- CHY and VVLDL are pathologic, only if their concentration in serum exceeds 500% of their mean concentration, and of course, in correlation with other classes, as well as VLDL. Both classes may, under pathologic conditions, far exceed even 1000% of their mean concentrations, however.
- IDL IDL-derived neurotrophic factor
- VLDL and LDL VLDL and LDL, resp. LDL j subclass.
- LDL is a diagnostically "sensitive” class. A 50% increase of LDL concentration is pathognomonic for the active stage of atherosclerosis.
- SUBSTITUTE SHEET cholesterol defined as greater than 150 mg% , is near 100% since it is directly assaying LDL and its subclasses. All other screening methods attempt to calculate
- HDL class is sensitively regulated genetically. Only in familial hyper- ⁇ - lipoproteinemia is this class elevated over 300 mg%, and in familial Tangier disease the class is almost completely absent. Pathognomonic is the case of human active atherogenesis characterized by a significant decrease of the concentration of this class
- HDI. ⁇ class A decrease of the HDL level under 150 mg% in serum has to be taken in serious consideration, although active atherogenesis may be characterized with values as low as 50 mg%.
- ME molecular electrophoresis
- SUBSTITUTE SHEET The quantification of the separated lipoprotein classes and subclasses may be accomplished using any acceptable means. Spectrophotometric techniques and the like are often used. Methods of quantification are readily apparent to those skilled in the art.
- Molecular electrophoresis constitutes not only a new analytical method, but a new analytical aim for practical and inexpensive molecular separation of lipoproteins into classes and diagnostically important subclasses.
- ME offers the only practical way for detection and definition of small metabolic changes, leading to and characterizing active phases of atherogenesis.
- the method of detecting active atherogenesis utilizes molecular electrophoresis. Molecular electrophoresis is used to separate and quantify lipoprotein classes and subclasses.
- a diagnostic condition which may be recognized, is a condition wherein the predetermined mean values of a lipoprotein class and subclass differ from the values obtained from a single sample.
- recognizing diagnostic conditions of active atherogenesis may be accomplished by comparing the values of lipoprotein classes and subclasses of a sample with the determined mean values of lipoprotein classes and subclasses.
- diagnostic conditions are characterized by a difference in the quantified values of a sample as compared to the determined mean values.
- diagnostic conditions are characterized by a sample's similarity to pathologic values of lipoprotein classes and subclasses.
- Pathologic values for lipoprotein classes and subclasses are defined elsewhere in this disclosure. It should be understood that pathologic values, just as mean values, may vary dependent upon the characteristics of a given geographic area. Furthermore, because human beings are individuals, specific pathologic values inherently vary from person to person.
- Figures 6, 7 and 8 demonstrate the effectiveness of the diagnostic method disclosed herein. The three spectrophotometric patterns indicate the presence of discrete lipoprotein classes and subclasses.
- Figure 6 is a spectrophotometric pattern of macromolecular serum lipoprotein classes from a known healthy human being.
- Figure 7 is a spectrophotometric pattern of macromolecular serum lipoprotein classes from a human being with mildly active atherogenesis.
- Figure 8 is a spectrophotometric pattern of macromolecular serum lipoprotein classes from a human being with severe active atherogenesis.
- Lipoprotein flotants may be separated on the precasted discontinuous, nonsequential agarose-polyacrylamide gel systems.
- Blood samples in EDTA are obtained on the morning of the cardiac catheterization after a 14 hour fast. Collected plasma samples are adjusted to 1.21 g/ml density by using NaCl and KBr, and centrifuged using Beckman Model L
- the gelatinous mixture for each layer of gel is prepared separately.
- a basic solution is provided which contains 1.6 ml of TRIS-Borate-Na 2 EDTA (TEE) buffer
- the mixture Before the use of the above mixture for a preparation of corresponding gelatinous layer, the mixture is removed from the water bath and cooled to 50 * - 55 * C. Next, 0.5 ml of 1.6% ammonium persulfate is added to each gelatinous mixture to quickly promote transfer to the gelatinous mold.
- the components are mixed and the selected portion (for example
- the electrophoresis of lipoprotein flotants and molecular weight standards is performed in a 10 cm long, 10 cm large and 2.0 nm thick vertical slab gels (casted in GSC-8 apparatus) at about 14 * C for the period of about 16 hours, 1 hour at about
- the lipoproteins separated in gels may be prestained (by mixing of equal volume of flotant with 5 g per L solution of Sudan Black B in ethylene glycol), or stained after a standard fixation (200 g trichloracetic acid in 1000 ml of distilled water) with Coomassie Blue G 250 for apolipoproteins (in a mixture of equal portions of acid copper sulfate solution and solved Coomassie Blue in diluted methanol), or
- the separated lipoproteins are fixed by heating at 72 * C.
- the gels are cut into two parts, so that they contain nearly identical samples.
- One part is stained with a solution of 0.1 % Coomassie Brilliant Blue R-250 in 50% ethanol and 9% acetic acid (v/v); the other part is stained with a solution of
- Fat Red 7B stain 0.2% Amido Black 10B in 5% acetic acid, and the final component with Fat Red 7B in alkaline solution.
- Fat Red 7B stain Four liters of Fat Red 7B stain are prepared by dissolving 0.9% g in absolute methanol containing stabilizer Triton-X-100. Working stain is prepared just before use. Staining is standardized by adjusting stain concentration against permanent colorimetric controls at 600 nm. After 15 minutes of staining with Fat
- the molecular weight standards used during molecular electrophoresis are Carboxylated Latex beads (DOW Chemicals), Thyroglobulin Dimer and Tyroglobulin (Pharmacia) with molecular diameters of 380 A, 236 A and 170 A respectively.
- the molecular weights of the above standards are : 5,388,333 daltons, 1,400,000 daltons and 669,000 daltons respectively.
- the marker proteins are: 0-lipoprotein (about 2 x 10 6 daltons), ⁇ -macroglobulin (about 820,000 daltons), thyroglobulin (about 669,000 daltons) apoferritin (about 443,000 daltons) and finally catalase (about 240,000 daltons).
- albumin is used (m.w. 68,000 daltons and size 71 A) as an electrophoretic migration marker (the albumin existed in a dimer form).
- the films are scanned at 520 nm on a scanning densitometer (microzone Digital Integrator, Model R-lll, Beckman Instruments, Inc. Spinco Division). The raw densitometric values are used to determine the relative proportion belonging to each major fraction, reported as percentage of the total area of the entire scan. The total counts per delimited area are also obtained and no correction factor is applied.
- a scanning densitometer microzone Digital Integrator, Model R-lll, Beckman Instruments, Inc. Spinco Division
- the scanning may be enhanced by using the Shimadzu Dual-Wavelength Scanner Model CS-930 (Shimadzu Corporation, California, USA) for densitometric
- Electroforetograms stained with Fat Red 7B in alkaline solution under standard conditions, are correlated with lipoprotein fractions that had been ultracentrifugally prepared, at standardized densities, and quantitated and then stained with Fat Red 7B under identical conditions : molecular weight standards of four main lipoprotein classes CHY + VNLDL, VLDL, LDL 2(3 are simultaneously analyzed electrophoretically and always stained on precasted nonuniform, discontinuous and nonsequential agarose - polyacrylamide gels.
- the age of the group of normals is 46.2 ( ⁇ 8.0) years, the age of the patient group is 52.0 ( ⁇ 7.1) years. The difference in age is slightly significant (p ⁇ 0.05).
- the mean severity of the CAD in the patient's group could be expressed by the mean grade 10.
- the products of molecular electrophoresis from the above group are characterized as follows:
- the first very thin and porous gelatinous layer (of 1.0 - 1.5% T) separates out only the largest molecules (e.g. 1,000 - 4,000 A) e.g. 100,000,000 daltons) to 350,000,000 daltons m.w.), representing exogenous chylomicrons (CHY). Usually, they constitute fraction "a", or its prefraction, if their concentration is extremely high.
- the second gelatinous layer (of 2.0% T) is characterized by K R , generally suitable to retard chylomicrons of hepatic origin of smaller particle size (600 - 900 A). Under physiological conditions, even the next group of lipoproteins (VVLDL) may be separated in this molecular sieve. 3.
- the third gelatinous layer (of 2.5% T) retains the chylomicron fragments, or NVLDL, characterized by a range of sizes (550 - 450 A) and molecular weights (approximately 80,000,000 - 25,000,000 daltons). Similarly, under physiologic conditions, even this class may contribute to the fraction "a”. 4.
- the fourth layer (of 3.0% T) represents the specific molecular sieve with retardation coefficient for VLDL forming few subclasses in the broad range of 600 to 400 A, e.g. in the range of 18,000,000 - 6,000,000 daltons (mean 12,000,000 daltons). Under physiologic conditions this class has only one, but may reveal up to four subclasses in pathologic stages. Fraction b. 5.
- the undivided LDL class includes lipoprotein particles with sizes ranging from 206 - 210 A and molecular weights from 4,000,000 - 1,500,000 daltons.
- the seventh layer (T - 4.8% ⁇ 0.2%) is adequate for K R and a proper
- density of netting may be calculated for Lp(a) if desired.
- the MDL render particles of size 200 - 190 A and m.w. 1,000,000 - 900,000 daltons and mean density 1.076 g/ml. Fraction h.
- the HDI ⁇ 2a (d 1.100-1.125 g/ml) includes lipoprotein in the size range 160-140 A.
- the HDL 3 3 a-c
- NVHDL mean banding position 1.342 g/ml
- protein content 98%.
- Two-way analysis of variance (fixed-effects model) and multiple comparisons is used to determine the significance of differences between groups in Figure 4.
- the two factors for analysis of variance are sex and the severity group (three levels).
- the chi-square statistic is used to assess differences between group 1 and group 2.
- the correlation between lipid determinations and severity of disease is examined by using stepwise linear regression analysis.
- the sensitivity and specificity of serum lipid levels and lipoprotein electrophoretic abnormalities in detecting patients with CAD are defined as follows:
- Sensitivity (%) true positives ⁇ 10 Q true positives + false negatives
- Predictive value (%) true posi t ives ⁇ 1( ⁇ ) true positives + false positives
- Triglycerides > 150 mg% 58% 48% 77%
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93916473A EP0645010A4 (en) | 1992-06-12 | 1993-06-09 | Diagnostic method for detection of active atherogenesis. |
AU46311/93A AU4631193A (en) | 1992-06-12 | 1993-06-09 | Diagnostic method for detection of active atherogenesis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89779092A | 1992-06-12 | 1992-06-12 | |
US07/897,790 | 1992-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993025897A1 true WO1993025897A1 (en) | 1993-12-23 |
Family
ID=25408422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/005520 WO1993025897A1 (en) | 1992-06-12 | 1993-06-09 | Diagnostic method for detection of active atherogenesis |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0645010A4 (en) |
AU (1) | AU4631193A (en) |
WO (1) | WO1993025897A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925229A (en) * | 1996-05-03 | 1999-07-20 | The Regents Of The University Of California | Low density lipoprotein fraction assay for cardiac disease risk |
WO2006128388A1 (en) * | 2005-06-03 | 2006-12-07 | Yunqin Chen | Method for gel electrophoresis separation of serum lipoproteins and quantization dection thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5078853A (en) * | 1991-03-22 | 1992-01-07 | Assay Technology, Inc. | Segmented electrophoretic separation system useful for lipid profiling |
-
1993
- 1993-06-09 AU AU46311/93A patent/AU4631193A/en not_active Abandoned
- 1993-06-09 EP EP93916473A patent/EP0645010A4/en not_active Withdrawn
- 1993-06-09 WO PCT/US1993/005520 patent/WO1993025897A1/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5078853A (en) * | 1991-03-22 | 1992-01-07 | Assay Technology, Inc. | Segmented electrophoretic separation system useful for lipid profiling |
Non-Patent Citations (3)
Title |
---|
Clinica Chimica Acta, Vol. 125 (1982), UBBINK et al., "The Direct Quantitation in whole Serum of HDL Subfractions", 165-175. * |
Clinical Chemistry, Vol. 37, No. 7 (1991), ATGER et al., "Cholesterol Distribution between High-Density-Lipoprotein Subfractions HDL2 and HDL3 Determined in Serum by Discontinuous Gradient Gel Electrophoresis", 1149-1152. * |
See also references of EP0645010A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925229A (en) * | 1996-05-03 | 1999-07-20 | The Regents Of The University Of California | Low density lipoprotein fraction assay for cardiac disease risk |
WO2006128388A1 (en) * | 2005-06-03 | 2006-12-07 | Yunqin Chen | Method for gel electrophoresis separation of serum lipoproteins and quantization dection thereof |
Also Published As
Publication number | Publication date |
---|---|
EP0645010A4 (en) | 1995-05-31 |
EP0645010A1 (en) | 1995-03-29 |
AU4631193A (en) | 1994-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Krauss et al. | Identification of multiple subclasses of plasma low density lipoproteins in normal humans. | |
Nikolac | Lipemia: causes, interference mechanisms, detection and management | |
Bradwell et al. | Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine | |
US5078853A (en) | Segmented electrophoretic separation system useful for lipid profiling | |
US5968332A (en) | Discontinuous and nonsequential polymeric gel systems for separation of macromolecules | |
Okazaki et al. | Recent advances in analytical methods on lipoprotein subclasses: calculation of particle numbers from lipid levels by gel permeation HPLC using “spherical particle model” | |
CA2513250A1 (en) | A serum marker for measuring liver fibrosis | |
Eto et al. | A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application | |
Galanakis et al. | Human fibrinogen heterogeneities: Distribution and charge characteristics of chains of Aα origin | |
Laurell | Electrophoresis, specific protein assays, or both in measurement of plasma proteins? | |
Le Bricon et al. | Sodium dodecyl sulfate-agarose gel electrophoresis of urinary proteins: application to multiple myeloma | |
Cheng et al. | Method for quantitating cholesterol in subfractions of serum lipoproteins separated by gradient gel electrophoresis | |
Bonhomme et al. | Mu-chain disease in an African patient | |
Komiya et al. | Low level of serum HDL-cholesterol with increased sIL-2R predicts a poor clinical outcome for patients with malignant lymphoma and adult T-cell leukemia-lymphoma | |
Srinivas | Introduction to protein electrophoresis | |
EP0563259B1 (en) | Discontinuous and nonsequential polymeric gel systems for separation of macromolecules | |
Martınez-Subiela et al. | Effects of haemolysis, lipaemia, bilirubinaemia and fibrinogen on protein electropherogram of canine samples analysed by capillary zone electrophoresis | |
Parente et al. | A new capillary zone electrophoresis method for the screening of congenital disorders of glycosylation (CDG) | |
Zhang et al. | Relation between insulin resistance and fast-migrating LDL subfraction as characterized by capillary isotachophoresis | |
Kamboh et al. | Genetic studies of Human Apolipoproteins: XV. An overview of IEF Immunoblotting methods to screen Apolipoprotein polymorphisms | |
WO1993025897A1 (en) | Diagnostic method for detection of active atherogenesis | |
Belcher et al. | A micro-enzymatic method to measure cholesterol and triglyceride in lipoprotein subfractions separated by density gradient ultracentrifugation from 200 microliters of plasma or serum. | |
Bautovich et al. | Gradient gel electrophoresis of human plasma lipoproteins | |
Zhao et al. | Relationship between apolipoprotein E and low density lipoprotein particle size | |
Westwood et al. | Analysis of the common genetic variants of the human Gc system in plasma and bloodstains by isoelectric focusing in immobilized pH gradients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1993916473 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993916473 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993916473 Country of ref document: EP |